| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $332.6M | +3.1% | +9.7% |
| Gross Profit | $77.0M | +0.1% | -0.3% |
| R&D Expense | $2.5M | -20.4% | -1.9% |
| SG&A Expense | $8.5M | -34.7% | -44.4% |
| Operating Income | $40.5M | +13.0% | -0.5% |
| Pre-tax Income | $44.0M | +7.5% | -8.0% |
| Income Tax | $6.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $334.9M | +39.5% | +53.9% |
| Short-term Investments | $31.0M | -50.7% | -26.5% |
| Accounts Receivable | $59.8M | -13.9% | -4.4% |
| Inventory | $176.4M | -5.6% | -3.8% |
| Current Assets | $622.0M | +7.7% | +17.9% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $126.3M | — | — |
| Capital Expenditures | $5.2M | — | — |
| Investing Cash Flow | $3.6M | — | — |
| Financing Cash Flow | -$57.7M | — | — |
| Free Cash Flow | $121.1M | — | — |
| +7.1% |
| -4.6% |
| Net Income | $37.2M | +7.6% | -8.6% |
| EPS (Basic) | $0.99 | +8.8% | +1.0% |
| EPS (Diluted) | $0.99 | +8.8% | +1.0% |
| $1.12B |
| +3.8% |
| +4.7% |
| Current Liabilities | $299.6M | +9.4% | +21.1% |
| Total Liabilities | $666.8M | +2.4% | -0.9% |
| Stockholders' Equity | $457.3M | +6.0% | +14.2% |